# Efficacy of Cannabidiol in Reducing Virulence of Listeria monocytogenes

**Authors:** Divya Joseph, Leya Susan Viju, Poonam Gopika Vinayamohan, Abraham Joseph Pellissery, Kumar Venkitanarayanan

PMC · DOI: 10.3390/ijms27062682 · 2026-03-15

## TL;DR

This study shows that cannabidiol (CBD) can reduce the harmful effects of Listeria monocytogenes without killing the bacteria, offering a new approach for food safety and treatment.

## Contribution

CBD is shown to suppress multiple virulence factors in Listeria monocytogenes at non-bactericidal levels, presenting a novel anti-virulence strategy.

## Key findings

- CBD at 6× SIC significantly reduced motility, toxin production, and host cell adhesion and invasion in Listeria monocytogenes.
- RT-qPCR revealed downregulation of key virulence genes like prfA, hly, and inlA in CBD-treated Listeria monocytogenes.
- CBD enhanced larval survival in a Galleria mellonella infection model in a dose-dependent manner.

## Abstract

Listeria monocytogenes (LM) is a major foodborne pathogen causing illnesses ranging from gastroenteritis to severe systemic infections. The key virulence factors include bacterial motility, hemolysin and lecithinase production, and invasion of host tissues. This study investigated the anti-virulence effects of cannabidiol (CBD), the main non-psychoactive compound in Cannabis sativa, against LM. The minimum inhibitory concentration (MIC, 2289 μM; 719.8 µg/mL) and sub-inhibitory concentration (SIC, 11.92 μM; 3.75 µg/mL) of CBD were determined for LM strains Scott A and ATCC 19115. Cultures were treated with SIC, 6× SIC, 1/4× MIC, and MIC to assess effects on motility, hemolysin and lecithinase production, and adhesion and invasion of human intestinal (Caco-2) and brain endothelial (HBMEC) cells, alongside virulence gene expression by RT-qPCR. Cannabidiol’s efficacy was also determined using a Galleria mellonella larval infection model at SIC and 6× SIC. Cannabidiol at 6× SIC significantly reduced motility, toxin production, and host cell adhesion and invasion (p < 0.05). RT-qPCR revealed downregulation of key virulence genes, including prfA, hly, plcA, plcB, iap, motA, motB, actA, inlA, and inlB. In vivo, CBD enhanced larval survival in a dose-dependent manner and cytotoxicity was observed at concentrations above 33.75 µg/mL. These results indicate that CBD, at non-bactericidal levels, effectively suppresses multiple virulence mechanisms in LM, highlighting its potential as a novel anti-virulence agent for food safety and therapeutic applications.

## Linked entities

- **Genes:** prfA (peptide chain release factor 1) [NCBI Gene 881360], KRCC1 (lysine rich coiled-coil 1) [NCBI Gene 51315], plcA (membrane-associated phospholipase A) [NCBI Gene 885995], plcB (phospholipase C) [NCBI Gene 880904], ALPI (alkaline phosphatase, intestinal) [NCBI Gene 248], FREM1 (FRAS1 related extracellular matrix 1) [NCBI Gene 158326], motB (flagellar motor protein MotB) [NCBI Gene 878217], ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58], inlA (internalin A) [NCBI Gene 985151], inlB (internalin B) [NCBI Gene 986892]
- **Chemicals:** cannabidiol (PubChem CID 644019), CBD (PubChem CID 644019)
- **Species:** Listeria monocytogenes (taxon 1639), Galleria mellonella (taxon 7137)

## Full-text entities

- **Genes:** FREM1 (FRAS1 related extracellular matrix 1) [NCBI Gene 158326] {aka BNAR, C9orf143, C9orf145, C9orf154, MOTA, TRIGNO2}, IAPP (islet amyloid polypeptide) [NCBI Gene 3375] {aka DAP, IAP}
- **Diseases:** infection (MESH:D007239), cytotoxicity (MESH:D064420), gastroenteritis (MESH:D005759)
- **Chemicals:** SIC (-), CBD (MESH:D002185)
- **Species:** Cannabis sativa (species) [taxon 3483], Listeria monocytogenes (species) [taxon 1639], Homo sapiens (human, species) [taxon 9606], Galleria mellonella (greater wax moth, species) [taxon 7137]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027152/full.md

---
Source: https://tomesphere.com/paper/PMC13027152